The effect of febuxostat on diastolic function in hyperuricemic patients with LV diastolic dysfunction

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2013
INTERVENTION: febuxisostat benzbromarone CONDITION: Hyperuricemia with LV diastolic dysfunction PRIMARY OUTCOME: E', E/E', BNP SECONDARY OUTCOME: MDA‐LDL, TNF‐alpha, adiponectin, urinary 8‐OHdG, ADMA, xanthine oxidase activity INCLUSION CRITERIA: hyperuricemic patients (>7.0) with LV diastolic dysfunction (E/E' >=15 OR 15>E/E'>=8 & BNP>200)
Epistemonikos ID: ce0f9ca0b22d819bf17bea7b4818565c33992386
First added on: Aug 22, 2024